Project A Multicenter, Phase 1/1b, Open-Label, Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects…

Basic data

Title:
A Multicenter, Phase 1/1b, Open-Label, Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects with Relapsed and Refractory Multiple Myeloma
Duration:
24/02/2016 to 23/02/2019
Abstract / short description:
A Multicenter, Phase 1/1b, Open-Label,
Dose-Escalation Study of ABBV-838, an Antibody
Drug Conjugate, in Subjects with Relapsed and
Refractory Multiple Myeloma
Keywords:
clinical trial
klinische Studie

Staff

Managers

Faculty of Medicine
University of Tübingen

Contact persons

Department of Radiology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Diagnostic and Interventional Radiology
Department of Radiology
Hospitals and clinical institutes, Faculty of Medicine

Funders

Wiesbaden, Hessen, Germany
Help

will be deleted permanently. This cannot be undone.